Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Mastocytosis

Mastocytosis is a group of rare disorders of both children and adults caused by the presence of too many mast cells and CD34+ mast cell precursors in a person's body. (From the Wikpedia article Mastocytosis.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Mastocytosis:

Pubmed Logo
Successful treatment of KIT D816V-positive, imatinib-resistant systemic mastocytosis with interferon-alpha.
We describe a case of systemic mastocytosis associated with...
17th November, 2009
Division of Hematology, Department of Internal Medicine, National Hospital Intern Med. 2009;48(22):1973-8. Epub 2009 Nov 16.
Anaphylaxis: Recent advances in assessment and treatment.
The incidence rate of anaphylaxis is increasing, particularly during the...
17th November, 2009
Department of Pediatrics, Faculty of Medicine, University of Manitoba, J Allergy Clin Immunol. 2009 Oct;124(4):625-36; quiz 637-8.
DOI Direct Link
On being metachromatic: Mystique and misunderstanding in mastocytosis.
We describe a case of systemic mastocytosis associated with...
10th November, 2009
Department of Medicine, Division of Hematology, Stanford University School Am J Hematol. 2009 Oct 23.
DOI Direct Link
Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis. Subcellular Distribution and Role of the Transforming Oncoprotein KIT D816V.
Recent data suggest that the signal transducer and activator of...
7th November, 2009
From the Department of Internal Medicine I,* Division of Hematology & Am J Pathol. 2009 Nov 5.
DOI Direct Link
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine.
Cytoreductive therapy in systemic mastocytosis (SM) includes several drugs...
6th November, 2009
Divisions of Hematology, Mayo Clinic, Rochester, Minnesota. Am J Hematol. 2009 Oct 9.
DOI Direct Link

View more research publications.

BioNews Results for Mastocytosis:

RSS Logo
BioPortfolio Logo
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
Journal of Investigative Dermatology:  Oct 29 2009 10:51AM Matching: mastocytosis

Mastocytosis Patents:

USPTO Logo
US Patent No.Title
7557106 Substituted pyrimidines useful as protein kinase inhibitors
7582629 Derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators
7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
7582654 Heterocyclo inhibitors of potassium channel function

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Mastocytosis scientists - we have details of around 213 individuals working on Mastocytosis .


This page has been viewed 519 times
Recent Search Terms used to find this page: AB1010 patent | AB1010 patent | mastinib | mastinib ab1010 | mastocytosis | mastinib patent | mastinib patent | masitinib patent | mastocytosis research | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Mastocytosis across BioPortfolio, or for Mastocytosis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.